• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

icotec Receives FDA Clearance for the CMORE® CT System, Expanding its BlackArmor® Engineered Carbon/PEEK Technology to the Posterior Cervicothoracic Spine

November 13, 2025 By SPINEMarketGroup

ALTSTÄTTEN, Switzerland and BOSTON, Nov. 13, 2025 /PRNewswire/ — icotec, the pioneer of implantable devices made from BlackArmor® Engineered Carbon/PEEK, today announced that the U.S. Food and Drug Administration (FDA) has cleared the CMORE® CT System for use in the cervicothoracic spine.

The CMORE® (CT) System is an enhanced set of instruments and implants for posterior stabilization of the upper spine. The world’s first spinal implants made of nonmetallic and radiolucent BlackArmor® technology now enable a full spectrum of treatment modalities in adjuvant tumor therapy and enhance postoperative imaging diagnostics in the cervicothoracic spine. Consisting of a full portfolio of polyaxial screws, straight and precontoured rods, axial and parallel connectors, the CMORE® CT System provides the versatility needed to accommodate variations in patients’ anatomy and pathology.

BlackArmor® Engineered Carbon/PEEK is a combination composite material with continuous, high strength carbon-fibers and PEEK, manufactured in a process developed by icotec. The result is an implant component with an interwoven 3D fiber architecture. It is also radiolucent in all diagnostic imaging modes (MRI, CT, and X-ray).

“The FDA clearance of the CMORE® CT System marks another milestone in our commitment to advancing care for patients with spinal tumors, infections, and complex pathologies,” said Christoph Eigenmann, CEO of icotec Medical, U.S. “By expanding our BlackArmor® technology to the posterior cervical spine, we’re giving surgeons and radiation oncologists a new level of visibility and confidence in their postoperative and oncological decision-making.”

icotec is excited for the upcoming commercial launch of the CMORE® CT System in the United States. This system will expand icotec’s portfolio of BlackArmor® Engineered Carbon/PEEK implants designed for artifact-free imaging and seamless integration across the spine.

About icotec

icotec is the leading company for the treatment of spinal tumors and other indications with a new generation of high-tech implants. With its BlackArmor® Engineered Carbon/PEEK implants, icotec combines cutting-edge technologies and industry expertise to deliver innovative and reliable solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation.

With a track record of clinical success and a commitment to continuous innovation, icotec is poised to shape the future of spinal surgery. The comprehensive product portfolio has received FDA and CE clearance and is supported by numerous Key Opinion Leaders and spine surgery centers worldwide.

Media Contact: 

Craig Wencis

Senior Vice President of Marketing and Education

craig.wencis@icotec-medical.com

For more information, visit www.icotec-medical.com

SOURCE icotec Medical

Related Posts:

  • CMORE® (CT) System
  • icotec’s VADER® Pedicle Systems: Axial and Parallel…
  • BlackArmor® Cervical Plate

Filed Under: FDA APPROVED, NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical: Stronger in Spine, but Could DePuy…
  • BROCHURES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • PRODUCT LIBRARY
  • Why Spine’s Commercial Model Needs a Reset? The real…
  • What Is Medtronic’s PILAR™ Technique?
  • Boston Scientific Puts $1.5 Billion on MiRus: Why…
  • Globus Medical: Strong Q1, Weak Stock Reaction — Is…
  • (2025 Update): Market, Leading FDA-Approved Devices,…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • COMPANIES
  • Single-Use Spine Surgery Systems: The Future or…
  • Modular Pedicle Screws: When Adaptability Becomes…
  • BoxSPINE Receives FDA Clearance for Rodless Spinal…
  • (UPDATED 2026) More Than 100 Options, No Single…
  • Orthofix Realigns Spine Leadership to Strengthen…
  • Autonomous Pedicle Screw Placement: Is Spine…
  • Cervical Fusion Implant Denials: Why Spine Societies…
  • Top 60+ Minimally Invasive Sacroiliac Joint Fusion…
  • VB Spine Announces VB Spine Solutions, a…
  • Hospital Access Is Gone. What Comes Next for Spine…
  • ATEC’s Valence: Robotics in Service of a Procedural Strategy
  • Johnson & Johnson Explores Potential $20B Sale…
  • Sublaminar Bands in Spine Surgery: Why This Small…
  • Orthofix Discontinues M6-C™ and M6-L™ Artificial…
  • Globus Medical Reports First Quarter 2026 Results
  • Expandable cages were adopted not because they fused…
  • VB Spine Signs Master Agreement with Apolo Medica
  • VB Spine Funds Landmark Research to Deliver the…
  • Medtronic Hits a 52-Week Low: What Is the Market Seeing?
  • LAST 5 VIDEOS PUBLISHED

    1. Syntropiq: Lyra
    2. ATEC Spine: SafeOp®
    3. REACH Medical: Expandable PLIF/TLIF Cage
    4. Expanding Innovations: X-PAC®TLIF 
    5. SI-BONE: iFuse INTRA Ti™ Implant System

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup